Clinical outcomes of exenatide versus basal insulin

Trial Identifier: D5551R00010
Sponsor:AstraZeneca
NCTID:NCT02987348
Start Date:June 2015
Primary Completion Date: June 2015
Study Completion Date: June 2015
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
UK Cardiff, UK, CF14 3QZ